Upstream Bio (UPB) Accounts Payables (2023 - 2025)
Historic Accounts Payables for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $4.0 million.
- Upstream Bio's Accounts Payables fell 1933.05% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 1933.05%. This contributed to the annual value of $4.0 million for FY2024, which is 10306.53% up from last year.
- Upstream Bio's Accounts Payables amounted to $4.0 million in Q3 2025, which was down 1933.05% from $2.6 million recorded in Q2 2025.
- Upstream Bio's 5-year Accounts Payables high stood at $4.9 million for Q3 2024, and its period low was $2.0 million during Q4 2023.
- Over the past 3 years, Upstream Bio's median Accounts Payables value was $4.0 million (recorded in 2024), while the average stood at $3.7 million.
- Per our database at Business Quant, Upstream Bio's Accounts Payables surged by 10306.53% in 2024 and then tumbled by 1933.05% in 2025.
- Quarter analysis of 3 years shows Upstream Bio's Accounts Payables stood at $2.0 million in 2023, then surged by 103.07% to $4.0 million in 2024, then dropped by 2.2% to $4.0 million in 2025.
- Its Accounts Payables stands at $4.0 million for Q3 2025, versus $2.6 million for Q2 2025 and $4.7 million for Q1 2025.